Table 1 Baseline characteristics of the discovery cohort according to the status of sarcopenia (144 men and 72 women).

From: Amino acid metabolites as potential circulating biomarkers for sarcopenia

Disease

Men (n = 144)

Women (n = 72)

Control (n = 72)

Sarcopenia (n = 72)

p

Control (n = 36)

Sarcopenia (n = 36)

p

Age (years)

74.0 [72.0; 76.0]

74.0 [72.0; 76.0]

0.989

70.4 ± 5.8

70.3 ± 5.7

0.935

Weight (kg)

72.7 [66.5; 79.5]

56.2 [51.2; 59.1]

< 0.001

65.2 [62.2; 70.1]

49.4 [46.0; 50.7]

< 0.001

Height (cm)

167.8 ± 4.8

163.0 ± 5.1

< 0.001

156.0 ± 3.9

151.7 ± 3.8

< 0.001

BMI (kg/m2)

26.1 [24.1; 27.9]

21.1 [19.4; 22.6]

< 0.001

26.8 [25.1; 29.1]

20.9 [19.7; 22.6]

< 0.001

Smoking, n (%)

  

0.002

  

0.602

Ex-smoker

57 (79.2%)

42 (58.3%)

 

0 (0.0%)

1 (2.8%)

 

Non-smoker

12 (16.7%)

13 (18.1%)

 

34 (94.4%)

35 (97.2%)

 

Current smoker

3 (4.2%)

17 (23.6%)

 

1 (2.8%)

1 (2.8%)

 

Drinking, n (%)

  

0.174

  

0.170

No alcohol

34 (47.2%)

41 (56.9%)

 

7 (19.4%)

3 (8.3%)

 

Alcohol < 1/week

20 (27.8%)

19 (26.4%)

 

2 (5.6%)

0 (0.0%)

 

Alcohol 1‒2/week

12 (16.7%)

4 (5.6%)

 

0 (0.0%)

1 (2.8%)

 

Alcohol ≥ 3/week

6 (8.3%)

8 (11.1%)

 

27 (75.0%)

32 (88.9%)

 

Exercise, n (%)

  

0.397

  

0.296

No exercise

6 (8.3%)

12 (16.7%)

 

4 (11.1%)

4 (11.1%)

 

Exercise < 1/week

4 (5.6%)

6 (8.3%)

 

3 (8.3%)

2 (5.6%)

 

Exercise 1‒2/week

12 (16.7%)

10 (13.9%)

 

7 (19.4%)

2 (5.6%)

 

Exercise ≥ 3/week

50 (69.4%)

44 (61.1%)

 

22 (61.1%)

28 (77.8%)

 

Hypertension, n (%)

50 (69.4%)

37 (52.1%)

0.051

24 (66.7%)

14 (38.9%)

0.034

Diabetes, n (%)

60 (95.8%)

64 (90.1%)

0.314

29 (80.6%)

29 (80.6%)

> 0.999

FM (kg)

21.6 [16.9; 23.9]

14.1 [11.2; 17.8]

< 0.001

25.5 [22.3; 28.6]

16.6 [14.8; 18.6]

< 0.001

pFM (%)

28.1 ± 6.2

25.0 ± 6.6

0.003

38.5 ± 5.3

33.3 ± 4.9

< 0.001

SARC-F

0.0 [0.0; 1.0]

1.0 [0.0; 2.0]

0.005

1.0 [0.0; 2.0]

0.0 [0.0; 2.0]

0.545

HGS (kg)

34.6 ± 7.0

28.5 ± 5.6

< 0.001

22.2 ± 5.1

20.8 ± 3.8

0.172

Chair stand up test (s)

7.0 [6.0;9.0]

7.0 [5.0;8.0]

0.874

9.0 [7.0; 11.0]

8.0 [6.0; 10.0]

0.462

LM (kg)

49.6 [47.7; 52.4]

39.8 [38.0; 41.6]

< 0.001

39.1 [37.2; 41.3]

30.8 [29.4; 32.0]

< 0.001

ASM (kg)

22.4 [21.4; 23.9]

16.9 [16.1; 18.2]

< 0.001

16.7 [15.8; 17.9]

12.3 [11.4; 13.0]

< 0.001

SMI (kg/m2)

8.0 [7.6; 8.4]

6.5 [6.2; 6.6]

< 0.001

6.9 [6.6; 7.2]

5.5 [5.0; 5.5]

< 0.001

  1. Data are presented as mean ± SD, median [IQR], or number (%).
  2. p: P value by Student’s t-test or Mann–Whitney U test for continuous variables or by chi-square or Fisher’s exact test for categorical variables.
  3. ASM, appendicular skeletal muscle mass; BMI, body mass index; EQ-VAS, EuroQol Visual Analogue Scale; FM, fat mass; HGS, hand grip strength; IQR, interquartile range; LM, lean mass; pFM, percent fat mass; SARC-F, Strength, Ambulation, Rising from a chair, stair Climbing, and history of Falling; SD, standard deviation; SMI, skeletal muscle mass index.
  4. Bold numbers indicate statistically significant values.